Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by cavinsinon Oct 13, 2017 9:01am
185 Views
Post# 26808751

RE:RE:RE:strong rumour on bay st

RE:RE:RE:strong rumour on bay stDont get me wrong I received 1 free share of GUD when PLB was sold, at the time around $4, so for me that was win/win situation, I just cant see them finding anything on fire sale, as some, expect. I hope they do, I would jump on the wagon heavily, but with more than 500 US Pharma companys, with lot more buying power then GUD has, it is proving a bit of chalenge to find that cheap asset, no? Believe me, pharma stocks are my concentration right now
Toronto housing market is down but you just cant find cheap house, no?
PFE is selling Advil for 14B, that would be good buy in my opinion, household name axross globe
Will see, but this one is on my radar daily, and ready to jump on it, if they are successful in buying lucrative asset.


Bullboard Posts